[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Hôpital Universitaire Sahloul\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":63},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100604298","evaluation-of-the-effectiveness-of-the-cardiostory-device-in-distinguishing-heart-failure-from-other-causes-in-patients-presenting-with-dyspnea-100604298",false,"NCT07147699","Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea","CARDIOSTORY","Inclusion Criteria:\n\n* • Age ≥ 18 years\n\n  * Recent onset dyspnea (less than 7 days)\n  * Informed consent obtained\n\nExclusion Criteria:\n\n* • Age inferior to 18 years,\n\n  * Severe comorbidity, hemodynamic compromise or immediate need for mechanical ventilation were exclusion criteria.\n  * Dyspnea clearly of traumatic or allergic origin","ALL","18 Years",{"count":19,"type":20},650,"ESTIMATED","OBSERVATIONAL","The CARDIOSTORY.TN study is a prospective observational study at Sahloul University Hospital (Sousse, Tunisia) evaluating the CardioStory device for distinguishing heart failure (HF) from other causes of acute dyspnea.\n\nBackground: Dyspnea is common in emergencies, and differentiating cardiac from non-cardiac causes is often delayed by the limits of echocardiography and BNP tests. CardioStory is a rapid (\\~2 minutes), non-invasive tool that measures cardiac filling pressure, a key HF marker.\n\nObjectives:\n\nPrimary: Assess CardioStory's diagnostic accuracy.\n\nSecondary: Compare it with echocardiography and NT-proBNP, evaluate ease of use, and measure time to diagnosis.\n\nMethods:\n\nAdults (≥18) with acute dyspnea (\\\u003C7 days) included; unstable or traumatic\u002Fallergic cases excluded.\n\nCardioStory results will be compared to standard diagnostics.\n\nSample size: 850 patients over 12 months.\n\nOutcome: If accurate, CardioStory could be a fast, practical diagnostic tool for emergency settings.",[24,25],"Dyspnea","Heart Failure Acute",[27,28],"dyspnea","acute heart failure","NOT_YET_RECRUITING","2025-08-28",{"date":32,"type":33},"2025-08-29","ACTUAL",{"date":35,"type":20},"2025-09-01",{"date":37,"type":20},"2026-12-01",{"name":39,"class":40},"Hôpital Universitaire Sahloul","OTHER",{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":49,"conditions":50,"keywords":4,"overallStatus":53,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},"100599806","external-validation-of-the-glasgow-blatchford-bleeding-score-in-a-tunisian-population-100599806","NCT07089277","External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population","Inclusion Criteria:\n\n* Adult patients (≥18 years) presenting with non-traumatic upper gastrointestinal bleeding\n\nExclusion Criteria:\n\n* patients under 18 years of age.\n\nDiagnosis of external hemorrhoids with mucosal lesions.\n\nPatients who do not consent, are lost to follow-up, or have incomplete data.",{"count":48,"type":20},250,"This study aims to externally validate the Glasgow-Blatchford Score (GBS) in a Tunisian population presenting with non-traumatic upper gastrointestinal bleeding. Despite advances in endoscopic management, early risk stratification remains essential to guide clinical decision-making. In Tunisia, the routine hospitalization of all patients for observation presents a challenge, highlighting the need for reliable prognostic tools.\n\nThe study is designed as a multicenter, descriptive, and analytical investigation across several emergency departments. Adult patients (≥16 years) will be included, with follow-up conducted at 30 days to assess for adverse outcomes including rebleeding, the need for hemostasis, complications, and mortality.\n\nClinical and epidemiological data will be collected using a standardized form. Statistical analysis will evaluate the predictive performance of the GBS, focusing on sensitivity, specificity, and predictive values for 30-day outcomes.\n\nThe results are expected to determine whether GBS is a valid and useful tool for risk assessment in the Tunisian context, potentially aiding in more efficient and targeted patient management.",[51,52],"Upper Gastrointestinal Bleeding (UGIB)","Glasgow-Blatchford Score","RECRUITING","2025-07-21",{"date":56,"type":33},"2025-07-28",{"date":58,"type":33},"2024-01-01",{"date":60,"type":20},"2025-12-30",{"name":39,"class":40},1,""]